Today, the FDA issued draft guidance outlining a new regulatory pathway intended to help sponsors gain approval for highly ...
Researchers at the Sanford Stem Cell Institute have taken the fight against rare diseases to the lab, to patients’ bedsides ...
The Food and Drug Administration (FDA) announced a new proposal Monday for flexible drug approval pathway treatments ...
FDA's Plausible Mechanism Framework streamlines individualized therapy approvals for ultra-rare diseases.
Rare disease day is observed annually on the last day of February to spread awareness on certain conditions that can impact on patients lives.
The framework was released as draft guidance on February 23.
Opinion
FDA Cruelly Holding Up Approval of Treatments for Rare Diseases, Despite Children Likely to Die Soon
The U.S. Senate Special Committee on Aging conducted a hearing on February 26 to investigate why the FDA is holding up the approval of desperately needed new drugs for those with rare diseases. Many ...
The FDA has sketched out its new regulatory pathway to market for individualised therapies that treat ultra-rare diseases, based on a 'plausible mechanism' premise.
Unusual headaches, vision changes, mood shifts or numbness? Know the subtle early warning signs of rare neurological ...
The Food and Drug Administration aims to evaluate treatments for rare diseases based on plausible evidence that they would ...
For some women, pregnancy is a time of profound loss. Not all pregnancies progress as expected. One serious complication is ectopic pregnancy, a condition in which a fertilized egg implants somewhere ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results